Sham device v inert pill: randomised controlled trial of two placebo treatments
- PMID: 16452103
- PMCID: PMC1370970
- DOI: 10.1136/bmj.38726.603310.55
Sham device v inert pill: randomised controlled trial of two placebo treatments
Abstract
Objective: To investigate whether a sham device (a validated sham acupuncture needle) has a greater placebo effect than an inert pill in patients with persistent arm pain.
Design: A single blind randomised controlled trial created from the two week placebo run-in periods for two nested trials that compared acupuncture and amitriptyline with their respective placebo controls. Comparison of participants who remained on placebo continued beyond the run-in period to the end of the study.
Setting: Academic medical centre.
Participants: 270 adults with arm pain due to repetitive use that had lasted at least three months despite treatment and who scored > or =3 on a 10 point pain scale.
Interventions: Acupuncture with sham device twice a week for six weeks or placebo pill once a day for eight weeks.
Main outcome measures: Arm pain measured on a 10 point pain scale. Secondary outcomes were symptoms measured by the Levine symptom severity scale, function measured by Pransky's upper extremity function scale, and grip strength.
Results: Pain decreased during the two week placebo run-in period in both the sham device and placebo pill groups, but changes were not different between the groups (-0.14, 95% confidence interval -0.52 to 0.25, P = 0.49). Changes in severity scores for arm symptoms and grip strength were similar between groups, but arm function improved more in the placebo pill group (2.0, 0.06 to 3.92, P = 0.04). Longitudinal regression analyses that followed participants throughout the treatment period showed significantly greater downward slopes per week on the 10 point arm pain scale in the sham device group than in the placebo pill group (-0.33 (-0.40 to -0.26) v -0.15 (-0.21 to -0.09), P = 0.0001) and on the symptom severity scale (-0.07 (-0.09 to -0.05) v -0.05 (-0.06 to -0.03), P = 0.02). Differences were not significant, however, on the function scale or for grip strength. Reported adverse effects were different in the two groups.
Conclusions: The sham device had greater effects than the placebo pill on self reported pain and severity of symptoms over the entire course of treatment but not during the two week placebo run in. Placebo effects seem to be malleable and depend on the behaviours embedded in medical rituals.
Figures





Similar articles
-
Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use.Pain. 2010 Apr;149(1):117-123. doi: 10.1016/j.pain.2010.01.016. Epub 2010 Feb 20. Pain. 2010. PMID: 20172654 Free PMC article. Clinical Trial.
-
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.Clin Ther. 2010 Dec;32(14):2348-69. doi: 10.1016/j.clinthera.2010.12.011. Clin Ther. 2010. PMID: 21353105 Clinical Trial.
-
Acupuncture for chronic low back pain: a multicenter, randomized, patient-assessor blind, sham-controlled clinical trial.Spine (Phila Pa 1976). 2013 Apr 1;38(7):549-57. doi: 10.1097/BRS.0b013e318275e601. Spine (Phila Pa 1976). 2013. PMID: 23026870 Clinical Trial.
-
A review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert.J Altern Complement Med. 2006 Apr;12(3):303-10. doi: 10.1089/acm.2006.12.303. J Altern Complement Med. 2006. PMID: 16646730 Review.
-
Are the Device Approval Standards Lax?JACC Cardiovasc Interv. 2025 Feb 10;18(3):380-384. doi: 10.1016/j.jcin.2024.08.037. JACC Cardiovasc Interv. 2025. PMID: 39939040 Review. No abstract available.
Cited by
-
Super Placebos: A Feasibility Study Combining Contextual Factors to Promote Placebo Effects.Front Psychiatry. 2021 Mar 4;12:644825. doi: 10.3389/fpsyt.2021.644825. eCollection 2021. Front Psychiatry. 2021. PMID: 33746801 Free PMC article.
-
Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study.BMC Complement Altern Med. 2008 Jul 7;8:37. doi: 10.1186/1472-6882-8-37. BMC Complement Altern Med. 2008. PMID: 18606019 Free PMC article. Clinical Trial.
-
The Signaling Theory of Symptoms : An Evolutionary Explanation of the Placebo Effect.Evol Psychol. 2015 Sep 1;13(3):1474704915600559. doi: 10.1177/1474704915600559. Evol Psychol. 2015. PMID: 37924177 Free PMC article.
-
Placebo Effects in Acupuncture.Med Acupunct. 2020 Dec 1;32(6):352-356. doi: 10.1089/acu.2020.1483. Epub 2020 Dec 16. Med Acupunct. 2020. PMID: 33362886 Free PMC article. Review.
-
Effect of different non-pharmacologic placebo treatments on migraine prevention: a network meta-analysis of randomized controlled trials.Acta Neurol Belg. 2024 Aug;124(4):1125-1139. doi: 10.1007/s13760-023-02460-2. Epub 2024 Jan 21. Acta Neurol Belg. 2024. PMID: 38245660 Review.
References
-
- Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet 1998;351: 1722-5. - PubMed
-
- http://placebo.nih.gov (accessed on 28 July 2005).
-
- Department of Health and Human Services. Elucidation of the underlying mechanism of placebo effect. http://grants1nih.gov/grants/guide/rfa-files/RFA-AT-02-002.html (accessed on 28 July 2005).
-
- Guess HA, Kleinman A, Kusek JW, Engel LW. The science of the placebo: toward an interdisciplinary research agenda. London: BMJ Publishing, 2002.
-
- Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344: 1594-602. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical